PreView PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization
The primary objective of this study is to assess the ability of the PreView PHP(study device)to detect newly diagnosed non-treated Choroidal Neovascularization (CNV)lesion associate with advanced Age-related Macular Degeneration (AMD) or Myopia and differentiate them from Intermediate AMD or Geographic Atrophy (GA)or patients with high Myopia with no CNV.
This study secondary is to enhance NotalVision normative database.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||PHP Preferential Hyperacuity Perimeter for the Detection of Choroidal Neovascularization|
|Study Start Date:||October 2003|
|Study Completion Date:||September 2007|
Newly diagnosed CNV
- The study is prospective, multi-center, comparative study.
- A clinical trail with FDA approval device (510K).
Please refer to this study by its ClinicalTrials.gov identifier: NCT00358345
|Tel Aviv Sourasky medical center|
|Tel Aviv, Israel|
|Study Director:||Ofer Sharon, MD||Notal Vision|